Mantis PRO is INVAMED's rotational thrombectomy platform engineered to pair mechanical clot fragmentation with high-vacuum aspiration for deep venous and arterial occlusions. This overview is intended for interventional clinicians evaluating combined rotational-aspiration systems for DVT and related thrombotic disease.
What Is Mantis PRO Rotational Thrombectomy & Ultra Aspiration?
Mantis PRO is a rotational system designed to deliver mechanical clot fragmentation together with strong aspiration capabilities in deep venous or arterial occlusions. The platform builds on the core Mantis leaf-tip design, adding an emphasis on high-vacuum aspiration intended to improve clearance of fragmented thrombus during the procedure.
What Are the Key Features of Mantis PRO?
- Rotating leaf-tip design — intended to engage and mechanically fragment thrombus of varying consistency
- Ultra aspiration capability — a high-vacuum aspiration mechanism designed to evacuate fragmented clot material efficiently
- Pharmacomechanical compatibility — engineered to support combined mechanical and pharmacologic clot management
- Flexible catheter construction — designed for navigability through variable and tortuous venous anatomy
- Precision rotational control — intended to allow operators to adapt technique to differing clot consistencies and locations
How Does the Combined Rotational-Aspiration Approach Work?
During a typical procedure, the catheter is advanced to the occlusion site under fluoroscopic guidance. The rotating leaf tip mechanically disrupts the thrombus while the integrated aspiration channel is engaged to draw fragmented material out of the vessel. This combined mechanism is intended to reduce residual clot burden compared to fragmentation alone, potentially reducing reliance on prolonged pharmacologic dissolution in appropriately selected cases.
Where Does Mantis PRO Fit Within DVT Management?
Mantis PRO is positioned as a mechanical/aspiration-based option within the spectrum of DVT interventions, alongside catheter-directed thrombolysis and pharmacomechanical thrombolysis systems such as Viper. Physicians typically select among these approaches based on clot burden, chronicity, vessel location (including iliofemoral involvement), and patient-specific factors. All endovascular thrombectomy procedures carry inherent risks, and device selection and patient suitability are determined by the treating physician.
What Should Clinicians Review Before Use?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Frequently Asked Questions
How does Mantis PRO differ from the standard Mantis leaf-tip system?
Mantis PRO emphasizes high-vacuum ("ultra") aspiration alongside the rotational leaf-tip mechanism shared across the Mantis platform, intended to enhance clearance of fragmented thrombus during the procedure.
Is Mantis PRO intended for arterial as well as venous occlusions?
Mantis PRO is designed for use in deep venous or arterial occlusions. Specific indications, vessel sizing, and contraindications should be confirmed against the official IFU before use.
Is Mantis PRO available worldwide?
Related INVAMED Resources
- Deep Vein Thrombosis (DVT) Product Portfolio
- Peripheral Arterial Disease (PAD)
- Request Information from INVAMED
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.